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Abstract 
INTRODUCTION: Male breast cancer is a very rare entity, representing less than 1% of all 
cancers affecting men (1, 2). Only 0.7% of all breast carcinomas are attributed to male breast 
cancer (3).  As a result, there is little published data worldwide and especially from South 
Africa about the imaging features of breast malignancy in men.  This study looked at the 
mammographic and ultrasound features of male breast cancer in the South African context. 
 
AIM:  To describe the imaging features of male breast cancer in a South African population. 
 
METHOD:  The histological reports of all patients who met the inclusion criteria were 
extracted from the National Health Laboratory Services (NHLS) patient records database and 
printed. The demographic data was used to trace the relevant diagnostic imaging studies 
that were performed for each patient. Only the mammography and ultrasound reports were 
reviewed, images were not re-reviewed.  
 
RESULTS: Seventy-six patients between the ages of 31 to 89 with confirmed primary breast 
malignancy were found in the NHLS database for the predetermined eleven-year period.  
Only 20 of the 76 had imaging reports available for assessment. Thirty-five percent of 
malignant lesions demonstrated microcalcifications, while 20% were spiculate, 20% irregular 
and 25% macrolobulated. On ultrasound, only 35% of lesions were hypoechoic with 20% 
demonstrating posterior acoustic shadowing. 
 
Invasive ductal carcinoma represented 91% of all primary male malignant breast lesions in 
our study population, with 8% of lesions attributed to invasive papillary carcinoma and only 
1% ductal carcinoma in-situ.  
 
CONCLUSIONS: Male breast cancer in South Africa is similar to male breast cancer 
elsewhere, not only on imaging but also on histology and immunohistochemistry.  
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1. Introduction 
1.1. Background 
Male breast cancer (MBC) is a very rare entity, representing less than 1% of all cancers 
affecting men (1, 2). Only 0.7% of all breast carcinomas are attributed to male breast cancer 
(3).  As a result, there is little published data worldwide and especially from South Africa 
about the imaging features of breast malignancy in men.  This study will look at the 
mammographic and ultrasound features of male breast cancer in the South African context. 
1.2. Anatomy and development of the breast 
At birth, the male and female breast is identical, composed predominantly of fibro-adipose 
stromal tissue and a few primary lactiferous ducts. It is only during puberty and under the 
influence of oestrogen that the characteristic glandular breast tissue in women develops. 
The male breast does not develop further and remains primarily unchanged with a lack of 
significant lobule formation (2). Hence, because of the similarities that male and female 
breasts share, breast cancer can present in a similar way in both sexes (4).  Due to its 
uncommonness, male breast cancer is far less studied, thus diagnostic and treatment 
protocols are deduced from those of the extensively studied female breast cancer (4). 
1.3. Epidemiology of male breast cancer worldwide 
Male breast cancer accounts for less than 1% of all cancers affecting men worldwide, making 
it an important, but rare disease. Chen describes the incidence of male breast cancer as 
increasing from 0.86 to 1.08 per 100 000 population over the last 25 years (2). This low 
incidence implies that since it is so uncommon and there is even less public awareness and 
education of the disease, no screening guidelines are in place (2, 3, 5, 6).  
 
In Europe, the annual incidence is reported to be 1 in 100 000, making it less prevalent than 
in developing countries such as Uganda and Zambia, where one study reported the incidence 
to be 5% and 15% respectively (7). In contrast to the high incidence in Africa, Japan was 
found to have a prevalence of 1 in 5 000 000 for male breast cancer (7). 
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There are no absolute risk factors for male breast cancer described thus far, but consistent 
associations have previously been recognised and published in the literature. Some of these 
known associations include: family history (especially in a first degree relative), Kleinefelter 
syndrome, BRCA1 and BRCA2 mutations, ionizing radiation exposure and radiation therapy 
to the chest, increasing age and conditions resulting in increased oestrogen levels(1, 3, 8, 9). 
Male breast cancer is often described as having similar characteristics to post-menopausal 
breast cancer in women (10, 11).  
 
Nahleh et al, in a study in 2007, found significant racial and gender differences in the 
presentation of breast cancer. In their study population, they found that the male breast 
cancer patients were more likely to be black. In contrast, the female breast cancer patient 
was more likely to be white. (12). 
 
1.4. Epidemiology of male breast cancer in the developing world 
1.4.1. Africa 
A meta-analysis done by Ndom et al found that the female to male ratio of breast cancer in 
Sub-Saharan Africa and in particular in central and southern African countries was 
significantly higher (1:0.049) than in their North African counterparts (1:0.027). They also 
suggested that there is a strong genetic basis of MBC based on observations of males of 
African origin residing in the United States who displayed a much higher male to female ratio 
in comparison with the surveyed Caucasian population (13). 
 
The general trend that is observed in African populations with regard to MBC is that it is 
usually diagnosed late and at a fairly advanced stage (12).  A number of reasons contribute 
to this finding, among which a lack of access to healthcare / resources and poor patient 
awareness of the disease are just a few (7, 11, 13).  These issues are not however limited to 
just MBC in Africa as similar findings were also demonstrated among the African female 
population. These are very important factors related to delay in diagnosis and therefore 
result in an increase in morbidity and mortality (7). 
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The most common histological type of breast cancer that is observed among African men is 
infiltrating ductal carcinoma and it is also the predominant type of breast cancer in men 
worldwide, accounting for more than 90% of all MBC cases (1, 7, 8, 13).  
 
1.4.2. South Africa 
There are very few published studies in the literature regarding MBC and its characteristics / 
features in the South African population. The latest statistics from the National Cancer 
Registry (NCR) of South Africa published for the year 2012 stated that there were 212 new 
MBC cases diagnosed in that year, resulting in a 1 in 738 lifetime risk in the South African 
population (14).  
 
This incidence was higher than the number of diagnosed cases of testis, myeloma and 
thyroid cancer respectively in South African men of that same year. Of the 212 new MBC 
cases diagnosed in 2012 in South Africa, 12 were Asian, 103 were African, 28 were coloured 
and 69 were white (14).  
 
In contrast to the statistical data published by the NCR for the year 2011, there is a clearly 
observed increase in the total number of newly diagnosed MBC cases from 149 to the 212 
reported for 2012 (14, 15). The increase is particularly noted in the black population, 
previously being 85. The incidence of MBC in the white population was almost doubled from 
36 to 69 newly diagnosed cases. The Asian and coloured populations also demonstrated a 
significant increase from 4 to 12 and 20 to 28 newly diagnosed cases respectively.  
In 2011 the lifetime risk was reported to be 1 in 922 (14, 15).  
 
The NCR is the main source for cancer statistics in South Africa and gathers its data only from 
public and private pathology laboratories across the country. Being a pathology-based 
registry only, results in under-reporting of many malignancies including that of male breast 
cancer. Based on the latest NCR data (for the year 2012), MBC in South Africa represents 
0.57% of all cancers diagnosed in men. This figure is much higher than the 0.17% reported by 
Mathew et al and demonstrates an increase from the 0.45% reported by the NCR for the 
previous year of 2011 (8, 14, 15).  
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1.5. Imaging of the male breast 
Mammography has long been the most reliable method of diagnosing breast cancer in both 
men and women with a sensitivity of 92% and specificity of 90% respectively (6). Ultrasound 
is also routinely used as a supplementary investigation to correlate mammography findings 
and to assist in obtaining image guided tissue biopsy for diagnosis (2, 6, 16).  
 
The most common mammographic feature of MBC is an eccentric, sub-areolar mass (6, 17, 
18). These masses are typically solid and often present with spiculated margins (19). Unlike 
its female equivalent, calcification is not a very common feature of MBC. When present, 
calcifications tend to be coarse, large and more scattered rather than the microcalcifications 
that are observed in female breast cancer (2, 17-20). 
 
On ultrasound, most masses are seen as ill-defined, irregular and hypoechoic (2, 17, 20). 
Cystic lesions in a male breast should always be seen as suspicious because papillary 
neoplasms commonly present as complex cystic masses (6). 
1.6. This project in context: Comparison to literature on the topic 
There is extremely little published data on the imaging features of MBC and male breast 
cancer in general and in the South African context. Recent literature on MBC is summarised 
in Table 1.1. 
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NS = Not specified
Table 1.1. A comparison of recent literature on male breast cancer 
Author 
Carrasco 
(2013) (16) 
Doyle 
(2011)  
(20) 
Mathew 
(2008) 
(8) 
Chen 
(2006)  
(2) 
Anderson 
(2005)  
(5) 
Gunhan-Bilgen 
(2002)  
(21) 
Appelbaum 
(1999)  
(1) 
No of malignant lesions 6 20 57 14 2984 14 12 
Age range (mean) 13 – 83 (48) 64 – 79 (NS) 19 – 80 (62) (67) 62 – 68 (NS) 53 – 84 (68.7) NS 
Site NS Subareolar Subareolar Subareolar NS Retroareolar Subareolar 
M
am
m
o
gram
 
Well-circumscribed 15.7% 15% 15% NS NS 23% 50% 
Ill-defined NS 46% 32% NS NS NS 43% 
Macrolobulated NS NS 20% NS NS 8% 42% 
Irregular NS NS 50% NS NS 69% NS 
Spiculate NS 39% 33% NS NS NS NS 
Microcalcifications NS 15% 29% NS NS 7% 25% 
U
ltraso
u
n
d
 
Borders NS 
62% ill-defined 
23% well-
defined 
44% micro- 
lobulated 
NS NS NS NS 
Internal echopattern NS 93% hypoechoic 76% hypoechoic hypoechoic NS NS NS 
Posterior echo 
features 
NS 
23% post 
shadowing 
NS 
14% post 
shadowing 
NS 
20% post 
enhancement 
NS 
H
isto
lo
gy 
DCIS 3.8% NS 11% NS NS 35-50% NS 
Invasive ductal 19.2% 80% 84% 85% 75.6% 85% 75% 
Invasive lobular NS 5% 3% NS NS NS NS 
Invasive papillary NS 5% 7% NS 23.4% NS NS 
Other NS 10% NS NS NS 14% NS 
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1.7. Study objectives 
The aim of the study was to describe and categorise mammographic and ultrasound features 
of male breast cancer in our study population. 
The study also described the histological and immunohistochemical findings of male breast 
cancer in our study population. 
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2. Materials and Methods 
This was a retrospective cross-sectional record review of male breast cancer patients in the 
database of the Division of Anatomical Pathology of the University of 
Witwatersrand/National Health Laboratory Service (NHLS) over an 11-year period. Ethics 
clearance was obtained to do the study, certificate number M140852 attached as Appendix 
A.  
2.1. Study population 
The study population included all male patients who underwent breast biopsies or surgery 
and were found in the database of the Division of Anatomical Pathology of the University of 
Witwatersrand/NHLS.   
2.2. Inclusion criteria 
All patients with biopsy proven carcinomas were considered for inclusion into the study. 
2.3. Exclusion criteria 
Patients with incomplete or illegible records were excluded from the study. 
2.4. Data collection 
The histological reports of all patients that met the inclusion criteria were extracted from the 
NHLS patient records database and printed. The demographic data was used to trace the 
relevant diagnostic imaging studies that were performed for each patient. Only the 
mammography and ultrasound reports were reviewed, images were not reviewed. Data for 
analysis was collected according to the attached data collection sheet (Appendix B) and 
captured in an Excel spreadsheet. No personal identifiable information was captured.  
2.5. Statistical analysis 
 The data obtained was analysed using descriptive statistics to determine the frequencies 
and percentages of pathology as identified on mammogram and ultrasound within the study 
population. The frequencies and percentages of histological findings were also reported. 
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3. Results 
Within the eleven-year period of 1 January 2004 to 31 December 2014, a total of 76 
histologically confirmed male breast cancers were found in the histology database of the 
University of Witwatersrand/NHLS. Only 20 (26%) of the total 76 were found to have 
radiological imaging. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.  Summary of total number of confirmed male breast cancers and available 
imaging reports 
 
Imaging reports were not available for several reasons  
 Imaging was never done - patient had biopsy and / or surgery without any imaging 
 Records at some hospitals are destroyed after 5 years, especially if patient demised 
 Handwritten reports that were illegible 
 Alternative names / misspelling of patient names or surnames 
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3.1. Demographics 
The age range of the sampled population was 31 to 89 years. 
The mean age at diagnosis, as well as the median age were both found to be 60 years. The 
mode was 63 years. Three patients did not have a record of their age. 
 
 
 
 
 
Number 
 
 
 
 
 
Age 
Figure 3.2. Age distribution of male patients with breast cancer 
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3.2. Mammographic features 
The mammographic (MMG) features were recorded on the 20 patients who were found to 
have imaging reports (Table 3.1).  
 
Table 3.1. Mammographic appearance of malignant lesions and of the contralateral breast 
 Mammographic features Number (%) (N = 20) 
Malignancy 
Microcalcifications 7 (35%) 
Macrolobulation 5 (25%) 
Irregular 4 (20%) 
Spiculated 4 (20%) 
Well-defined 1 (5%) 
Contralateral breast 
Gynaecomastia 3 (15%) 
Microcalcifications 1 (5%) 
Normal 12 (60%) 
Unspecified 3 (15%) 
NOTE: percentages do not total to 100 because of rounding. 
 
Microcalcifications were demonstrated in 7 patients (35%). A macrolobulated mass lesion 
was described in 5 cases (25%). Four lesions (20%) were irregular and another 4 (20%) were 
spiculated. A well-defined lesion was described in only one patient (5%).  
 
On mammographic review of the contralateral breast (Table 3.1.), three patients (15%) 
demonstrated gynaecomastia, one (5%) had microcalcifications and 3 (15%) were 
unspecified. The remaining 12 (60%) demonstrated normal mammographic features with no 
suspicious characteristics. 
 
Examples of mammographic findings of breast cancer in male patients are shown in Figures 
3.3 to 3.6 below.  
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Figure 3.3. Invasive ductal carcinoma with microcalcifications on mammogram in a male 
patient 
 
  
Left mediolateral oblique 
(MLO) mammogram image of 
a 45-year-old male patient, 
showing a retroareolar mass 
(solid line) with irregular 
margins and associated 
microcalcifications (arrow). 
Additionally, there is 
overlying skin thickening 
(arrowhead).  
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Figure 3.4. Invasive ductal carcinoma with no microcalcifications on mammogram in a 
male patient 
  
Right mediolateral oblique 
mammogram image of a 59-
year-old male patient, 
showing an irregular 
retroareolar mass (solid line) 
with associated skin 
thickening (arrow). No 
calcifications were noted in 
this mass.  
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Figure 3.5. Invasive papillary carcinoma on mammogram in a male patient with 
gynaecomastia of the contralateral breast.  
  
Bilateral mediolateral 
oblique mammographic 
images of an 82-year-old 
male patient 
demonstrating a right 
retroareolar 
macrolobulated mass 
(solid line) with spiculated 
inferior border and 
associated nipple 
retraction. Additionally, 
there is an involved 
intramammary lymph 
node (arrowhead) within 
the right axillary tail. 
The contralateral breast 
demonstrates benign 
proliferation of 
retroareolar 
fibroglandular tissue 
(arrow) representing 
gynaecomastia. 
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Figure 3.6. Invasive papillary carcinoma on mammogram in a male patient  
  
Right mediolateral 
oblique 
mammographic image 
of a 79-year-old male 
patient, 
demonstrating a 
retroareolar 
macrolobulated mass 
(solid line). There is no 
involvement of the 
nipple. 
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3.3. Ultrasound features 
Upon analysis of the 20 available ultrasound reports of histologically confirmed male breast 
cancers, 5 (25%) were noted to be solid, 3 (15%) were cystic and a further 3 (15%) were 
mixed solid/cystic. 
A hypoechoic internal echopattern was recorded in 7 of the patients (35%) with posterior 
acoustic shadowing in 4 (20%). Three (15%) of the malignant lesions were found to have 
irregular borders and only 1 (5%) had spiculated borders on ultrasound (Table 3.2.). 
 
Table 3.2. Ultrasound appearance of malignant lesions 
Ultrasound features Number (%) (N=20) 
Solid 5 (25%) 
Cystic 3 (15%) 
Solid/cystic  3 (15%) 
Hypoechoic 7 (35%) 
Posterior acoustic shadowing 4 (20%) 
Irregular borders 3 (15%) 
Spiculated 1 (5%) 
NOTE: percentages do not total to 100 because of rounding. 
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Figure 3.7. Invasive ductal carcinoma with microcalcifications on ultrasound in a male 
patient 
 
 
 
 
 
  
Ultrasound image of the 
patient seen in Figure 
3.3. above with invasive 
ductal carcinoma, 
demonstrating a 
heterogeneous mass 
with irregular 
microlobulated margins 
(solid line) with multiple 
internal hyperechoic 
foci (arrowheads) 
representing 
microcalcifications. 
Note that this mass is 
separable from the 
underlying pectoralis 
major muscle (arrow). 
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Figure 3.8. Invasive ductal carcinoma on ultrasound in a male patient 
 
 
 
 
 
 
 
  
Ultrasound image of the 
patient seen in Figure 
3.4. above with invasive 
ductal carcinoma 
demonstrating a solid 
irregular hypoechoic 
retroareolar mass (solid 
line) with areas of 
posterior acoustic 
shadowing (arrows). 
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Figure 3.9. Example of an ultrasound image of male breast cancer – invasive papillary 
carcinoma  
  
Ultrasound image of the 
patient seen in Figure 
3.6. above with invasive 
papillary carcinoma 
demonstrating a 
lobulated mass with 
anechoic cystic (arrows) 
and heterogeneous 
solid (arrowheads) 
components. There is 
posterior acoustic 
enhancement (stars) 
related to the cystic 
components. 
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3.4. Histological features 
Seventy-six male patients with breast cancer were identified in the NHLS database during 
the study period. The histological findings were collected on all the patients, whether they 
had imaging available or not. 
 
Invasive ductal carcinoma was found in 69 patients (91%). Three patients (4%) were noted to 
have invasive ductal carcinoma with a micropapillary component, and a further 3 (4%) were 
intraductal papillary carcinomas. Ductal carcinoma in situ was found in only one patient, 
representing 1% (Table 3.3.). 
 
Table 3.3. Histological features 
Histology Number (%) (N=76) 
Invasive Ductal Carcinoma 69 (91%) 
Invasive Papillary Carcinoma 6 (8%) 
Ductal Carcinoma In Situ 1 (1%) 
Other 0 (0%) 
 
3.5. Molecular prognostic markers 
Oestrogen and progesterone receptor markers were analysed in all but two patients (99%). 
Her2NEU analysis was performed in 71 patients (93%).  
Ki67 index was performed in only 23 (30%) of the total 76 patients. 
 
3.5.1. Oestrogen receptor status 
Sixty-three (83%) patients were found to be Oestrogen receptor (ER) positive and 11 (14%) 
were ER negative (Table 3.4.). Two patients (3%) had no record of molecular prognostic 
marker testing and thus ER status was unknown. 
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Table 3.4. Oestrogen receptor status 
Receptor status Number (%) (N=76) 
Positive 63 (83%) 
Negative 11 (14%) 
Unknown 2 (3%) 
 
3.5.2. Progesterone receptor status 
Progesterone receptor (PR) status was tested in all but 2 (3%) patients (Table 3.5.). Fifty-two 
(68%) of the cancers were found to be receptor positive and 22 (29%) were receptor 
negative.  
 
Table 3.5. Progesterone receptor status 
Receptor status Number (%) (N=76) 
Positive 52 (68%) 
Negative 22 (29%) 
Unknown 2 (3%) 
 
3.5.3. Her2NEU receptor status 
Her2NEU receptor status was tested only on 71 patients (Table 3.6.). A positive receptor 
status was noted in 16 patients (21%). Of the total 76 patients, 41 (54%) were Her2NEU 
receptor negative, 14 (18%) were equivocal and 5 (7%) were unknown. 
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Table 3.6. Her2NEU receptor status 
Receptor status Number (%) (N=76) 
Positive 16 (21%) 
Negative 41 (54%) 
Equivocal 14 (18%) 
Unknown 5 (7%) 
 
3.5.4. Ki67 Index 
Ki67 index was not consistently tested in all patients. It was performed in only 23 (30%) of 
the total 76 patients and thus will not be discussed further in this study. 
 
3.5.5. Combined analysis of molecular prognostic markers 
A triple negative result (ER, PR and Her2NEU) was noted in only 4 (5%) patients. 
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3.6. Laterality and site of malignant lesions 
Based on histological reports 33 (43%) cancers were left-sided, 36 (47%) right-sided and 7 
(9%) were unspecified (Table 3.7.). 
 
Retro-areolar location was noted in 22 patients (29%), followed by lower outer quadrant in 9 
(12%), upper outer quadrant in 8 (11%), lower inner quadrant in 5 (7%) and upper inner 
quadrant in 3 (4%). Quadrant location was unspecified in 29 (38%) patients (Table 3.7.). 
 
Table 3.7. Laterality and site of malignant lesions 
  Number (%) (N = 76) 
Side 
Left 33 (43%) 
Right 36 (47%) 
Unknown 7 (9%) 
Location 
Retro-areolar 22 (29%) 
Lower outer quadrant 9 (12%) 
Upper outer quadrant 8 (11%) 
Lower Inner quadrant 5 (7%) 
Upper inner quadrant 3 (4%) 
Unspecified 29 (38%) 
NOTE: percentages do not total to 100 because of rounding. 
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4. Discussion 
Mammography is the most reliable radiological method of diagnosing breast cancer with a 
sensitivity and specificity of 92% and 90% respectively (6). The main purpose of this study 
was to describe the imaging features of breast cancer in male patients in our study 
population. To our knowledge, this study is the first descriptive study of its kind in South 
Africa.  
 
There is a paucity of literature on male breast cancer, both internationally and locally. Table 
4.1. below compares the mammographic, ultrasound and histological data of our study to six 
other descriptive studies in the literature. All the studies describing imaging features are 
rather small, mostly less than 20 patients. The largest study that could be found in the 
English-speaking literature was done by Mathew et al who reported 57 cases in 2008 (8). 
4.1. Results in context 
4.1.1. Demographics 
Male breast cancer is a very rare entity. According to the NCR between 110 to 145 males 
have been diagnosed with breast cancer annually in South Africa between the period of 
2002 and 2011, with a steep increase of 212 newly diagnosed cases in 2012 (14). This study 
only identified 76 patients over an 11-year period at the NHLS in Johannesburg.  
 
The age distribution of our study was broad, ranging from 31 to 89 years of age. The mean 
age at diagnosis was found to be 60 years. This is comparable to the study by Mathew et al 
who reported a mean age at diagnosis of 62 in their study (8). The studies by Kreiter et al 
and Otto et al described male breast cancer as having a similar clinical presentation as post-
menopausal breast cancer in women (10, 11). This was confirmed by the Anderson study, 
which found that the incidence of male breast cancer increases with advancing age (5). The 
demographics in our study reflect a similar pattern. 
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NS = Not specified, MMG = Mammogram
Table 4.1. Comparison of current study to recent literature on male breast cancer 
Author 
Kaloianova 
(2017) 
Current study 
Doyle 
(2011)  
(20) 
Mathew 
(2008) 
(8) 
Chen 
(2006)  
(2) 
Anderson 
(2005)  
(5) 
Gunhan-Bilgen 
(2002)  
(21) 
Appelbaum 
(1999)  
(1) 
No of malignant lesions 76 (20 MMG) 20 57 14 2984 14 12 
Age range (mean) 31-89 (60) 64 – 79 (NS) 19 – 80 (62) (67) 62 – 68 (NS) 53 – 84 (68.7) NS 
Site Retroareolar Subareolar Subareolar Subareolar NS Retroareolar Subareolar 
M
am
m
o
gram
 
Well-circumscribed 5% 15% 15% NS NS 23% 50% 
Ill-defined 0% 46% 32% NS NS NS 43% 
Macrolobulated 25% NS 20% NS NS 8% 42% 
Irregular 20% NS 50% NS NS 69% NS 
Spiculate 20% 39% 33% NS NS NS NS 
Microcalcifications 35% 15% 29% NS NS 7% 25% 
U
ltraso
u
n
d
 
Borders 
15% irregular 
5% spiculated 
62% ill-defined 
23% well-
defined 
44% micro- 
lobulated 
NS NS NS NS 
Internal echopattern 35% hypoechoic 93% hypoechoic 
76% 
hypoechoic 
hypoechoic NS NS NS 
Posterior echo 
features 
20% post 
shadowing 
23% post 
shadowing 
NS 
14% post 
shadowing 
NS 
20% post 
enhancement 
NS 
H
isto
lo
gy 
DCIS 1% NS 11% NS NS 35-50% NS 
Invasive ductal 91% 80% 84% 85% 75.6% 85% 75% 
Invasive lobular 0% 5% 3% NS NS NS NS 
Invasive papillary 8% 5% 7% NS 23.4% NS NS 
Other 0% 10% NS NS NS 14% NS 
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4.1.2. Site and laterality of malignant lesion 
Our study found 29% of lesions to be sited in a retroareolar location. In the 
literature, the terms “retroareolar” and “subareolar” are used interchangeably. All 
the comparable studies that were found stated either “retroareolar” or “subareolar” 
as the commonest site for the lesions in their studies. This is in keeping with the fact 
that the male breast tissue is concentrated in the retroareolar region (4). 
 
There was no statistically significant difference in the laterality of the malignant 
lesions in our study where 43% were left sided and 47% were right sided. Those with 
an unknown location accounted for 9% of the total number of lesions.  
 
4.1.3. Mammography findings  
Only 20 (26%) of the total 76 patients with histologically confirmed malignancies in 
our study had breast imaging reports available for analysis. This figure is concordant 
with only 23% of patients imaged that was reported by Mathew et al (8). 
A significant number of our patients had biopsies and / or surgery without any 
imaging, however there were also cases of lost, destroyed or illegible reports, 
decreasing the number of imaging reports available for assessment.  
 
The most common finding in our study was that of microcalcifications, found in 35% 
(7 of 20) of our patients. This was higher that the incidence of microcalcifications 
described in the international literature. Mathew and Appelbaum reported 29% and 
25% respectively (1, 8). Gunhan-Bilgen and Doyle reported even lower incidences of 
7% and 15% respectively (20, 21). 
 
Macrolobulation was the second most common finding in our study, with 25% of our 
patients showing macrolobulation on MMG. This is similar to what Mathew et al 
have shown, at 20% (8). The frequency of macrolobulation otherwise varies in the 
literature from 8% (Gunhan-Bilgen et al) to 42% (Appelbaum et al) (1, 21). 
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4.1.4. Ultrasound features  
Ultrasound is commonly used as a supplement to confirm mammographic findings 
(2, 6, 16). In our centres, it is routinely done for all patients undergoing 
mammography and it is highly user dependent.  
 
Mathew and Doyle found that more than two thirds of the malignant lesions in their 
respective studies demonstrated a hypoechoic internal echopattern (8, 20). Internal 
echopattern was stated in only 35% of patients in our study, and was documented as 
hypoechoic in all these cases. In the remaining 65% of patients echogenicity of the 
lesion was not commented upon. In our review, it was noted that 15% of lesions 
were described as irregular, 5% as spiculated and 20% as demonstrating posterior 
acoustic shadowing. Review of the ultrasound reports highlighted an inconsistent 
use of the standardised Breast Imaging Reporting and Data System (BI-RADS) 
terminology, making it very difficult to extract data that would be comparable with 
other studies. 
4.1.3. Histological features  
Invasive ductal carcinoma was by far the most prevalent histological type of breast 
cancer in our study population, accounting for 91% of all malignant breast lesions. 
This finding is similar to that noted by Mathew et al and Chen et al, who reported 
the prevalence of invasive ductal carcinoma to be 84% and 85% in their respective 
studies (2, 8).  
 
The second most common histological type of breast cancer in this study was 
invasive papillary carcinoma, which made up 8% of the total. Mathew et al described 
a comparable finding of 7% in their study population (8). In contrast to the above 
data, Anderson et al reported a 23.4% prevalence of invasive papillary carcinoma (5).  
 
Ductal carcinoma in-situ (DCIS) was only present in 1% of our study population. 
Mathew noted an 11% DCIS prevalence (8). There are various factors that could 
explain this difference. Lack of access to healthcare and delayed presentation due to 
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poor patient awareness are possible reasons for this apparent discrepancy. (7, 11, 
13). 
4.1.3. Molecular prognostic markers 
Our literature review revealed very few studies that published data relating to 
molecular prognostic markers in male breast cancer. When reported, only oestrogen 
and progesterone receptor status were analysed. In our study we considered 
oestrogen, progesterone and Her2NEU receptor status.  
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Table 4.2. Comparison of molecular prognostic markers of current study with 
recent literature 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE: percentages do not total 100 because of rounding; NS = Not specified 
 
The discordance in data in Table 4.2 above is postulated to be as a result of ethnic 
genetic differences considering the diverse populations and geographic locations 
that were surveyed in each study. Further research in this field is needed. 
 
It is extremely important to assess the combined status of the three molecular 
markers in the context of each tumour. Triple negative breast cancer (ER, PR and 
Her2NEU negative) in both men and women is known to be particularly resistant to 
hormonal therapy and other commonly used chemotherapeutic agents (22). 
A total of 4 out of 76 patients (5%) in our study were triple negative. 
Author 
Kaloianova 
(2017)  
Current study 
Mathew 
(2008) 
(8) 
Anderson 
(2005)  
(5) 
Number (%) N=76 (100%) N=244 (100%) N=1855 (100%) 
O
e
stro
gen
 
rece
p
to
r 
Positive 63 (83%) 110 (45%) 1097 (59.1%) 
Negative 11 (14%) 11 (5%) 112 (6.0%) 
Unknown 2 (3%) 123 (50%) 646 (34.8%) 
P
ro
gestero
n
e 
rece
p
to
r 
Positive 52 (68%) 84 (34%) 936 (50.5%) 
Negative 22 (29%) 26 (11%) 228 (12.3%) 
Unknown 2 (3%) 134 (55%) 691 (37.3%) 
H
er2
N
EU
 rece
p
to
r 
Positive 16 (21%) NS NS 
Negative 41 (54%) NS NS 
Equivocal 14 (18%) NS NS 
Unknown 5 (7%) NS NS 
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4.2. Current applications  
Although primary male breast cancer is rare, it is extremely important to apply the 
same protocols that are applied in the diagnosis and imaging of female breast 
cancer. Mammography and ultrasound form the mainstay of this diagnosis. Thus, we 
recommend performing both mammography and breast ultrasound on all male 
patients presenting with breast symptoms and supplying the managing clinical team 
with a standardised report using BI-RADS descriptors.  
4.3. Limitations of the current study 
A significant limitation of this study is that it is a retrospective review of a single 
histological laboratory’s data set of 76 histologically confirmed MBC, of which only 
20 comprehensive imaging reports could be retrieved. An important factor involved 
in this limitation included poor record-keeping of imaging reports.  
 
Additionally, we found multiple discrepancies and inconsistencies, especially in the 
ultrasound reports in our centres, which provided only a vague description of 
lesions. Examples include not providing comments on the internal echo pattern of 
lesions and simply describing a breast mass as a “space-occupying lesion”.   
4.4. Future applications  
For our study, we compiled a data-collection checklist (Appendix B) that was adapted 
from common imaging descriptors used in mammography and breast ultrasound in 
the radiology literature. Based on the widespread use of non-standard descriptors 
that we found in the imaging reports in our centres, we would strongly like to 
encourage the use of and adherence to international reporting standards that are 
outlined in the latest BI-RADS lexicon for the reporting of MMG and ultrasound 
findings of every patient (male and female) undergoing breast imaging in our 
centres. Adherence to these guidelines will assist in standardising our imaging 
reports and greatly facilitate future data collection and analysis. Ultimately this 
strategy will improve and encourage further research in MBC.  
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5. Conclusion 
We have shown that male breast cancer in South Africa is similar to male breast 
cancer elsewhere, not only on imaging but also on histology and 
immunohistochemistry.  
 
Although this is a rare condition, radiologists have an important role to play in 
communicating findings to clinicians in a concise way in order to facilitate and 
expedite appropriate treatment. 
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Appendix B: Data collection sheet 
Study no  
Age  
Site of lesion  
M
am
m
o
gram
 featu
res 
Well-defined  
Ill-defined  
Irregular  
Macrolobulated  
Spiculate  
Microcalcifications  
Other breast  
U
ltraso
u
n
d
 featu
res 
Solid  
Cystic  
Internal echopattern  
Posterior echo features  
Borders  
H
isto
lo
gy 
DCIS  
Invasive Ductal Carcinoma  
Invasive Papillary Carcinoma  
Invasive Lobular Carcinoma  
Receptor Status (ER, PR, Her2)  
Other  
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Appendix C: Note on referencing style 
Please note that the referencing in this thesis is a modification of the Vancouver 
Referencing style, done according to the Faculty of Health Sciences Style Guide as set 
out by the Wits Health Sciences Library. 
 
The information on this WHSL Vancouver Citation Style Guide for Theses, 
Dissertations and Research Reports is available from 
http://libguides.wits.ac.za/whsl-vancouver updated on 30 January 2017. 
 
